Literature DB >> 9316722

Hypercholesterolemia: an association with osteonecrosis of the femoral head.

J T Moskal1, R E Topping, L L Franklin.   

Abstract

To determine whether hypercholesterolemia is an associated factor for idiopathic avascular necrosis, serum cholesterol levels were measured in all patients presenting with idiopathic avascular necrosis of the femoral head from December 1987 to December 1995. Of 77 patients, with 114 affected hips, presenting with avascular necrosis of the femoral head, 58 patients, with 81 affected hips, were excluded for known associated risk factors. Of the remaining 19 patients (33 hips) who were diagnosed with idiopathic avascular necrosis, 16 had serum cholesterol levels that were statistically elevated (mean value, 254 mg/dL) compared with accepted age-matched control standards (P < 0.0031). Four of the 16 patients were taking cholesterol-lowering medications at the time of initial evaluation and testing. In addition, 12 of the 16 patients had bilateral avascular necrosis, suggesting that the systemic effect of hypercholesterolemia may be involved in the pathophysiology of osteonecrosis. These results suggest an association between elevated serum cholesterol levels and idiopathic avascular necrosis of the femoral head.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9316722

Source DB:  PubMed          Journal:  Am J Orthop (Belle Mead NJ)        ISSN: 1078-4519


  20 in total

Review 1.  Osteonecrosis of the femoral head associated with pigmented villonodular synovitis.

Authors:  Shoji Baba; Goro Motomura; Junichi Fukushi; Satoshi Ikemura; Kazuhiko Sonoda; Yusuke Kubo; Takeshi Utsunomiya; Hiroyuki Hatanaka; Yasuharu Nakashima
Journal:  Rheumatol Int       Date:  2016-12-07       Impact factor: 2.631

2.  High risk of osteonecrosis of the femoral head in autoimmune disease patients showing no immediate increase in hepatic enzyme under steroid therapy.

Authors:  Shunichiro Okazaki; Satoshi Nagoya; Motohisa Yamamoto; Kenji Tateda; Hiroki Takahashi; Toshihiko Yamashita; Hiroshi Matsumoto
Journal:  Rheumatol Int       Date:  2012-01-04       Impact factor: 2.631

Review 3.  Avascular necrosis of the femoral head after single steroid intra-articular injection.

Authors:  Ali A Al-Omari; Abdelwahab J Aleshawi; Omar A Marei; Hamza M Bani Younes; Khaled Z Alawneh; Esra'a ALQuran; Ziyad M Mohaidat
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-09-19

4.  High triglyceride is a risk factor for silent osteonecrosis of the femoral head in systemic lupus erythematosus.

Authors:  Takeshi Kuroda; Naohito Tanabe; Ayako Wakamatsu; Chinatsu Takai; Hiroe Sato; Takeshi Nakatsue; Yoko Wada; Masaaki Nakano; Ichiei Narita
Journal:  Clin Rheumatol       Date:  2015-09-18       Impact factor: 2.980

Review 5.  [Pain management in non-juvenile, aseptic osteonecrosis].

Authors:  M Jäger; A Werner; S Lentrodt; U Mödder; R Krauspe
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

6.  Investigation of occurrence of osteonecrosis of the femoral head after increasing corticosteroids in patients with recurring systemic lupus erythematosus.

Authors:  Fumio Sekiya; Ken Yamaji; Kwangseok Yang; Hiroshi Tsuda; Yoshinari Takasaki
Journal:  Rheumatol Int       Date:  2009-10-07       Impact factor: 2.631

7.  Can health care databases be used to identify incident cases of osteonecrosis?

Authors:  Steven C Vlad; David T Felson; Donald R Miller
Journal:  Arthritis Res Ther       Date:  2009-06-17       Impact factor: 5.156

8.  Glucocorticoid-induced avascular bone necrosis: diagnosis and management.

Authors:  K L Chan; C C Mok
Journal:  Open Orthop J       Date:  2012-10-05

9.  Significant association of SREBP-2 genetic polymorphisms with avascular necrosis in the Korean population.

Authors:  Tae-Ho Kim; Jeong-In Baek; Jung Min Hong; Su-Jin Choi; Hye-Jin Lee; Hyun-Ju Cho; Eui Kyun Park; Un-Kyung Kim; Shin-Yoon Kim
Journal:  BMC Med Genet       Date:  2008-10-27       Impact factor: 2.103

10.  Rationale for prostaglandin I2 in bone marrow oedema--from theory to application.

Authors:  Marcus Jäger; Frank Peter Tillmann; Thomas S Thornhill; Marcus Mahmoudi; Dirk Blondin; Gerd Rüdiger Hetzel; Christoph Zilkens; Rüdiger Krauspe
Journal:  Arthritis Res Ther       Date:  2008-10-03       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.